{"raw_mentions": "In some embodiments, provided herein is an antibody or antigen-binding fragment thereof that binds to human Dectin- 1, wherein the antibody or fragment binds to human Dectin- 1 expressed on the surface of a cell with an EC50 of less than 2nM, less than InM, or less than 0.5nM."}
{"final_json": [{"molecule_name": "antibody or antigen-binding fragment", "protein_target_name": "human Dectin-1", "binding_metric": "EC50", "value": "<2nM", "unit": "nM"}, {"molecule_name": "antibody or antigen-binding fragment", "protein_target_name": "human Dectin-1", "binding_metric": "EC50", "value": "<1nM", "unit": "nM"}, {"molecule_name": "antibody or antigen-binding fragment", "protein_target_name": "human Dectin-1", "binding_metric": "EC50", "value": "<0.5nM", "unit": "nM"}]}
{"raw_mentions": "In some embodiments, the first antigen-binding domain: binds to human Dectin- 1 expressed on the surface of a macrophage, monocyte, dendritic cell, or granulocyte; binds to human Dectin- 1 expressed on the surface of a cell with an EC50 of less than 2nM; is capable of binding human or cynomolgus Dectin-1; and/or does not compete with anative ligand of human Dectin-1."}
{"final_json": [{"molecule_name": null, "protein_target_name": "human Dectin-1", "binding_metric": "EC50", "value": "<2", "unit": "nM"}]}
{"raw_mentions": "Anti-Dectin-l/anti-hCD70 bispecific binds Dectin-1- or CD70-expressing cells with an affinity of 1.8 nM or 12.34 nM, respectively.\nFIG. 12B also depicts the EC50 concentration (nM) based on a non-linear regression fitting (bottom right)."}
{"final_json": [{"molecule_name": "Anti-Dectin-l/anti-hCD70 bispecific", "protein_target_name": "Dectin-1, CD70", "binding_metric": "affinity", "value": "1.8", "unit": "nM"}, {"molecule_name": "Anti-Dectin-l/anti-hCD70 bispecific", "protein_target_name": "Dectin-1, CD70", "binding_metric": "affinity", "value": "12.34", "unit": "nM"}, {"molecule_name": null, "protein_target_name": null, "binding_metric": "EC50", "value": null, "unit": "nM"}]}
{"raw_mentions": "None of the sentences in the provided text meet the criteria of containing all four required components: a specific molecule name, ID or other identifier, a bioactivity metric (IC50, Ki, Kd, EC50 and their variations), a specific numeric value for that metric, and a unit for that value. The text primarily describes experimental methods, results, and comparisons without providing specific bioactivity metrics with numeric values and units."}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nFIGS. 55A-55D show binding of 2M24/Trop-2 bispecific antibody to Trop-2-expressing cell lines HeLa (FIG. 55A), BxPC-3 (FIG. 55B), SiHa (FIG. 55C), and Capan-2 (FIG. 55D). Binding EC50, as determined using four-parameter logistic (4PL) non-linear regression, is shown for each cell line."}
{"final_json": [{"molecule_name": "2M24/Trop-2 bispecific antibody", "protein_target_name": "Trop-2", "binding_metric": "EC50", "value": null, "unit": null}]}
{"raw_mentions": "In some embodiments, the antigen binding domain, antibody, or antibody fragment binds to human Dectin-1 expressed on the surface of a cell with an EC50 of less than 5nM, less than 2nM, less than InM, or less than 0.5nM."}
{"final_json": [{"molecule_name": null, "protein_target_name": "human Dectin-1", "binding_metric": "EC50", "value": "<5nM", "unit": "nM"}, {"molecule_name": null, "protein_target_name": "human Dectin-1", "binding_metric": "EC50", "value": "<2nM", "unit": "nM"}, {"molecule_name": null, "protein_target_name": "human Dectin-1", "binding_metric": "EC50", "value": "<1nM", "unit": "nM"}, {"molecule_name": null, "protein_target_name": "human Dectin-1", "binding_metric": "EC50", "value": "<0.5nM", "unit": "nM"}]}
{"raw_mentions": "There are no sentences that meet the specified criteria. The text does not contain specific molecule names, bioactivity metrics (IC50, Ki, Kd, EC50), numeric values, and units. It appears to be a general description of methods and concepts related to antigen-binding domains and multispecific binding molecules."}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nThe 2M24 anti-Dectin-1 antibody was superior to commercial antibodies tested in terms of affinity, exhibiting an EC50 of 0.3 nM.\nThe agonistic 15E2 and the 255931 commercial antibodies exhibited EC50 of 14 nM and 16 nM, respectively, in cynomolgus monkey monocytes.\nAs shown in FIGs. 3A-3B, the fully human 2M24 showed high affinity binding to Dectin- 1 in transfected HEK cells (EC50 = 1.6 nM) and human monocytes (EC50 = 0.7 nM)."}
{"final_json": [{"molecule_name": "2M24 anti-Dectin-1 antibody", "protein_target_name": "Dectin-1", "binding_metric": "EC50", "value": "0.3", "unit": "nM"}, {"molecule_name": "15E2", "protein_target_name": null, "binding_metric": "EC50", "value": "14", "unit": "nM"}, {"molecule_name": "255931", "protein_target_name": null, "binding_metric": "EC50", "value": "16", "unit": "nM"}, {"molecule_name": "2M24", "protein_target_name": "Dectin-1", "binding_metric": "EC50", "value": "1.6", "unit": "nM"}, {"molecule_name": "2M24", "protein_target_name": "Dectin-1", "binding_metric": "EC50", "value": "0.7", "unit": "nM"}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nAs shown in FIG. 12B, binding studies on cells revealed that 2M24/anti-hCD70 bound to the HEK293 cell line expressing Dectin-1 with an EC50 of 1.8 nM and bound to CD70-positive renal carcinoma cell lines with an EC50 of 12.34 nM (A498 cells) or 11.62 nM (786-0 cells)."}
{"final_json": [{"molecule_name": "2M24/anti-hCD70", "protein_target_name": "Dectin-1", "binding_metric": "EC50", "value": "1.8", "unit": "nM"}, {"molecule_name": "2M24/anti-hCD70", "protein_target_name": "CD70", "binding_metric": "EC50", "value": "12.34", "unit": "nM"}, {"molecule_name": "2M24/anti-hCD70", "protein_target_name": "CD70", "binding_metric": "EC50", "value": "11.62", "unit": "nM"}]}
{"raw_mentions": "Here is the extracted sentence:\n\nAs shown in FIGs. 20A-20C, the Fab 2M24-mSA fusion showed high affinity binding (EC50 = 1.45 nM) to Dectin-1 expressing cells."}
{"final_json": [{"molecule_name": "Fab 2M24-mSA fusion", "protein_target_name": "Dectin-1", "binding_metric": "EC50", "value": "1.45", "unit": "nM"}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n1. In PBMCs from donor 83, the EC50 with respect to CD19 expression was 0.014nM for rituximab and 0.080nM for 2M24/CD20 hlgGl bispecific (FIG. 37A).\n2. In PBMCs from donor 84, the EC50 with respect to CD19 expression was 0.013nM for rituximab and 0.090nM for 2M24/CD20 hlgGl bispecific (FIG. 37B).\n3. The EC50 with respect to CD19 expression was 0.020nM for rituximab and 0.95nM for 2M24/CD20 hlgGl bispecific."}
{"final_json": [{"molecule_name": "rituximab", "protein_target_name": "CD19", "binding_metric": "EC50", "value": "0.014", "unit": "nM"}, {"molecule_name": "2M24/CD20 hlgGl bispecific", "protein_target_name": "CD19", "binding_metric": "EC50", "value": "0.080", "unit": "nM"}, {"molecule_name": "rituximab", "protein_target_name": "CD19", "binding_metric": "EC50", "value": "0.013", "unit": "nM"}, {"molecule_name": "2M24/CD20 hlgGl bispecific", "protein_target_name": "CD19", "binding_metric": "EC50", "value": "0.090", "unit": "nM"}, {"molecule_name": "rituximab", "protein_target_name": "CD19", "binding_metric": "EC50", "value": "0.020", "unit": "nM"}, {"molecule_name": "2M24/CD20 hlgGl bispecific", "protein_target_name": "CD19", "binding_metric": "EC50", "value": "0.95", "unit": "nM"}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nThe secondary antibody (AF647 goat Anti-Human) was used for detection by flow cytometry. Binding EC50 was determined using four-parameter logistic (4PL) non-linear regression. \n Binding EC50 was determined using four-parameter logistic (4PL) non-linear regression. The results demonstrated that 2M24/Trop-2 bispecific antibody binds with variable sub-micromolar affinity to different Trop-2-expressing cell lines (FIGS. 55A-55D).\n Cancer cell lines (HeLa, SiHa, BxPC-3, and Capan-2) were incubated with serial dilutions of the 2M24/Trop-2 hlgGlbispecific antibody or an isotype control antibody as a single concentration (300 nM)."}
{"final_json": [{"molecule_name": "2M24/Trop-2 bispecific antibody", "protein_target_name": "Trop-2", "binding_metric": "EC50", "value": "sub-micromolar", "unit": null}, {"molecule_name": "2M24/Trop-2 hlgGlbispecific antibody", "protein_target_name": null, "binding_metric": null, "value": "300", "unit": "nM"}]}
{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n\nBinding EC50 values were determined using four parameter logistic (4PL) non-linear regression. \n\n\nNote: Unfortunately, there is only one sentence that contains all four required components: a specific molecule name (\"2M24/Nectin-4 bispecific antibody\"), a bioactivity metric (\"EC50\"), but it lacks a specific numeric value and unit for that metric. However, I extracted this sentence as it comes closest to meeting the criteria. If you would like, I can try to re-analyze the text to see if any other sentences might be relevant."}
{"final_json": [{"molecule_name": null, "protein_target_name": null, "binding_metric": "EC50", "value": null, "unit": null}]}
